Oplysning til sundhedspersoner om det mulige behov for at justere dosis for patienter, der normalt behandles uden for Europa med Xyntha. • Betydningen af at indberette formodede bivirkninger, herunder inhibitorforekomst, med angivelse af navn og batchnummer på det anvendte produkt.
Advice for health care professionals on possible need to adjust dosages for patients normally treated outside Europe with Xyntha. • The importance to report suspected adverse reactions (including inhibitor occurrence) detailing the name and the batch number of the product used.